Cigna earnings beat by $0.04, revenue topped estimates
In a remarkable display of market confidence, Alphatec Holdings , Inc. (NASDAQ:ATEC) stock has achieved a new 52-week high, reaching a price level of $13.03, with analysts setting targets as high as $22.50. According to InvestingPro data, the company has demonstrated robust revenue growth of ~26% over the last twelve months, reaching $642 million. This milestone underscores the company’s significant growth trajectory over the past year, which is further evidenced by an impressive 1-year change of 17.32%. Investors have shown increasing enthusiasm for ATEC’s prospects, rallying behind the company’s strategic initiatives and market performance, propelling the stock to this new height. The 52-week high serves as a testament to Alphatec Holdings’ robust financial health, supported by a healthy current ratio of 2.75, and the positive sentiment surrounding its future in the competitive medical technology landscape. For deeper insights into ATEC’s valuation and growth prospects, access the comprehensive Pro Research Report available exclusively on InvestingPro.
In other recent news, Alphatec Holdings Inc. reported mixed results for the first quarter of 2025. The company’s earnings per share (EPS) fell short of analyst expectations, posting a loss of $0.35 compared to the anticipated loss of $0.12. However, revenue slightly exceeded forecasts, reaching $169 million against the expected $167.98 million, marking a 22% increase year-over-year. Notably, surgical revenue grew by 24%, reflecting strong adoption of Alphatec’s procedures. The company also reported an adjusted EBITDA of $11 million, representing a 6% margin, despite a slight decline in gross margin by 50 basis points to 70%. Alphatec’s strategic initiatives include the development of a robotic system and expansion of the EOS informatics platform, as highlighted in their earnings call. Analysts from firms like Lake Street Capital Markets and Wells Fargo (NYSE:WFC) have shown interest in these developments, with discussions around market potential and tariff exposure. Alphatec remains focused on international expansion, particularly in regions like Australia, New Zealand, and Japan, as part of its growth strategy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.